by Virtus | Jan 6, 2026 | Viral & Rhinovirus Models
Human rhinovirus preclinical models are increasingly used in preclinical antiviral model programmes to support respiratory drug development and mechanism-focused preclinical respiratory studies. Rhinovirus is one of the most common viral triggers linked to...
by Virtus | Dec 22, 2025 | Viral & Rhinovirus Models
Rhinovirus infection models are widely used in preclinical antiviral research to investigate respiratory viral pathogenesis, evaluate therapeutic efficacy, and support early-stage respiratory drug development. Rhinoviruses are a common cause of respiratory infections...
